An AI implementation partner for private equity is a firm that embeds engineering teams inside portfolio companies to identify, build, and maintain AI systems that drive measurable EBITDA impact and stays accountable through production and post-launch.The defining characteristic is ownership after go-live. The same team that scoped the use case owns what happens when the data breaks, the model drifts, or the integration fails.

The downstream revenue loss from referral leakage reaches $800,000 to $900,000 per physician per year. Not from billing errors. Not from denied claims. From referrals that were written and never completed. At a 100-provider multi-specialty group, that is $78 to $97 million in annual revenue that left the network silently, without a single denied claim to flag it.

Claude Code is configurable. The model it uses for reasoning and code generation sits underneath the interface and you can swap it. Most teams using Claude Code have never tested what happens when you do.

Between October 2025 and March 2026, Anthropic, OpenAI, and Amazon Web Services each launched a purpose-built healthcare AI platform. Not general-purpose AI with a compliance disclaimer. Purpose-built, HIPAA-aligned products targeting clinical operations, revenue cycle, life sciences, and patient access.

Your competitor shipped an AI assistant last quarter. Your board has asked three times in the last two meetings when you're shipping yours. Your VP of Product has a roadmap that includes "AI integration" in the next sprint cycle.

Somewhere in the last twelve months, the question changed. It used to be "should we be looking at AI?" Now it's "why aren't we further along?"